GB202313506D0 - Liquid or gelled pharmaceutical formulations of opicapone - Google Patents

Liquid or gelled pharmaceutical formulations of opicapone

Info

Publication number
GB202313506D0
GB202313506D0 GBGB2313506.4A GB202313506A GB202313506D0 GB 202313506 D0 GB202313506 D0 GB 202313506D0 GB 202313506 A GB202313506 A GB 202313506A GB 202313506 D0 GB202313506 D0 GB 202313506D0
Authority
GB
United Kingdom
Prior art keywords
opicapone
liquid
pharmaceutical formulations
gelled pharmaceutical
gelled
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2313506.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bial Portela and Cia SA
Original Assignee
Bial Portela and Cia SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bial Portela and Cia SA filed Critical Bial Portela and Cia SA
Priority to GBGB2313506.4A priority Critical patent/GB202313506D0/en
Publication of GB202313506D0 publication Critical patent/GB202313506D0/en
Ceased legal-status Critical Current

Links

GBGB2313506.4A 2023-09-05 2023-09-05 Liquid or gelled pharmaceutical formulations of opicapone Ceased GB202313506D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB2313506.4A GB202313506D0 (en) 2023-09-05 2023-09-05 Liquid or gelled pharmaceutical formulations of opicapone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2313506.4A GB202313506D0 (en) 2023-09-05 2023-09-05 Liquid or gelled pharmaceutical formulations of opicapone

Publications (1)

Publication Number Publication Date
GB202313506D0 true GB202313506D0 (en) 2023-10-18

Family

ID=88296614

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2313506.4A Ceased GB202313506D0 (en) 2023-09-05 2023-09-05 Liquid or gelled pharmaceutical formulations of opicapone

Country Status (1)

Country Link
GB (1) GB202313506D0 (en)

Similar Documents

Publication Publication Date Title
IL279464A (en) Pharmaceutical formulation of odevixibat
EP4175629A4 (en) Transdermal pharmaceutical formulations for the treatment of multiple sclerosis
GB202010464D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
IL285141A (en) Liquid pharmaceutical formulations of pth conjugates
ZA202207188B (en) Liquid tasimelteon formulations and methods of use thereof
EP4171544A4 (en) Pharmaceutical formulations of griseofulvin for long-term ocular delivery
IL285073A (en) Concentrated liquid pharmaceutical formulations of furosemide and methods of administering the same
GB202313506D0 (en) Liquid or gelled pharmaceutical formulations of opicapone
GB202212883D0 (en) Liquid or gelled pharmaceutical formulations of opicapone
SG11202112010RA (en) PHARMACEUTICAL FORMULATIONS OF FcRn INHIBITORS SUITABLE FOR SUBCUTANEOUS ADMINISTRATION
GB202002786D0 (en) Liquid pharmaceutical composition
GB202110420D0 (en) Liquid pharmaceutical composition of clonidine
EP3968955A4 (en) Pharmaceutical oral liquid solution of ivacaftor
IL285751A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
IL286416A (en) Abiraterone-cyclic oligomer pharmaceutical formulations and methods of formation and administration thereof
EP3965739C0 (en) Tablet dosage formulations of oleyl phosphocholine
GB202112511D0 (en) Liquid or gelled pharamaceutical formulations of opicapone
EP3714902C0 (en) Stabilization of pharmaceutical compositions comprising polysorbate
EP4153140A4 (en) Oral liquid formulations of lenvatinib
AU2023276829A1 (en) Liquid pharmaceutical formulations of cnp compounds
GB202207690D0 (en) Liquid pharmaceutical formulation of bisoprolol
EP3466409C0 (en) Self-emulsifying compositions of weakly ionizable or non-ionizable active pharmaceutical ingredients
GB202209022D0 (en) Pharmaceutical compositions and formulations for the treatment of retinoblastoma
CA196836S (en) Dose cup for liquid medicinal formulations
IL314206A (en) Pharmaceutical formulation

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)